Check a prediction score for steroid response in severe autoimmune hepatitis
Part of Digestive system, Immune system & allergy clinical trials.
This study looks at how well a scoring system can predict whether steroids will work in people with a severe, sudden autoimmune liver inflammation. If you qualify, your doctors may use your test results to estimate the chance steroids will help and compare that estimate to real outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Doctors strongly suspect severe acute autoimmune hepatitis based on blood tests (like IgG/autoantibodies) and/or liver biopsy, and other causes have been ruled out
- Your INR (a blood test related to liver function) is 1.5 or higher
- You can give written informed consent and you have French social insurance rights
- You have not taken corticosteroids in the last month
- You are not currently pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at specific immune cells (T cells) in the blood of people with autoimmune hepatitis (AIH) to better understand the disease. If you have untreated AIH and meet certain criteria, you may be able to participate.
This study looks at factors that help predict how well people with autoimmune hepatitis respond to treatment. It is for patients who are newly diagnosed or have not had treatment for at least 3 months, and who have had a liver biopsy to confirm the diagnosis.
This study looks at whether a specific blood marker can predict which patients with liver inflammation will need long-term steroid treatment. It may help doctors decide the best treatment for you if you have unexplained liver injury.
This trial checks if the absence of certain antibodies in autoimmune hepatitis (AIH) is linked to more severe disease. It may help doctors better understand and treat AIH.
This trial tests whether a short course of steroids (anti-inflammatory medication) can help people with severe alcohol-associated hepatitis. It aims to see if this treatment improves liver function and survival.
This trial tests whether a procedure called therapeutic plasma exchange (TPE) — which cleans harmful substances from your blood — is more effective than standard medicines for treating severe autoimmune hepatitis. It may be an option if your condition is very serious and you are not able to get a liver transplant within the next month.
Hear when a new Risk Factors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.